However, in the interest of lung cancer, VVs preferably target cells with expression of the scavenger receptor MARCO, which, according to the human protein atlas (HPA), is enhanced in lung cancers (Sjöstedt et al., 2020). The gene discussed is MARCO; the disease is lung carcinoma.